Holen Sie sich die Stockscreener-App
33.55
7.01%
2.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$31.32
Offen:
$31.53
24-Stunden-Volumen:
601.87K
Relative Volume:
0.65
Marktkapitalisierung:
$1.74B
Einnahmen:
$225.21M
Nettoeinkommen (Verlust:
$-15.70M
KGV:
-99.08
EPS:
-0.3386
Netto-Cashflow:
$-4.78M
1W Leistung:
+2.78%
1M Leistung:
+5.63%
6M Leistung:
+87.86%
1J Leistung:
+81.16%
1-Tages-Spanne:
$31.46
$33.63
1-Wochen-Bereich:
$30.00
$33.63
52-Wochen-Spanne:
$9.215
$36.00
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
33.52 | 1.63B | 225.21M | -15.70M | -4.78M | -0.3386 |
ABT
Abbott Laboratories
|
102.60 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.25 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.75 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.40 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.09 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Wells Fargo | Overweight |
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
AXGN: Canaccord Genuity Maintains 'Buy' Rating with $40 Target | - GuruFocus
Risk Recap: Is Axogen Inc in a bullish channel2026 Technical Patterns & Weekly Breakout Stock Alerts - baoquankhu1.vn
AXGN: Canaccord Genuity Maintains 'Buy' Rating with $40 Target | AXGN Stock News - gurufocus.com
AxoGen's (AXGN) "Buy" Rating Reaffirmed at Canaccord Genuity Group - MarketBeat
Do options traders know something about Axogen stock we don't? - MSN
Trading Recap: Is Axogen Inc stock influenced by commodity pricesBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
(AXGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Nasdaq Moves: How correlated is Axogen Inc to the S P5002026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth - AOL.com
AxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know - AOL.com
Vanguard realigns reporting; Axogen (NASDAQ: AXGN) shows 0 shares owned - Stock Titan
Assenagon Asset Management S.A. Purchases 90,777 Shares of AxoGen, Inc. $AXGN - MarketBeat
DAFNA Capital Management Sells Axogen Shares in 2025News and Statistics - IndexBox
This $6.5 Million Healthcare Reduction Follows a 71% Increase in Stock Price and 20% Rise in Revenue - Bitget
AxoGen, Inc. (NASDAQ:AXGN) Q4 2025 earnings call transcript - MSN
Is Axogen (AXGN) Fairly Priced After Strong 72.7% One Year Share Gain - Yahoo Finance
Axogen chief innovation officer DeVinney sells $171k in shares By Investing.com - Investing.com Australia
Axogen chief innovation officer DeVinney sells $171k in shares - Investing.com
Erick Wayne Devinney Sells 5,221 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen (AXGN) officer nets shares after RSU vesting and sale - Stock Titan
Axogen (AXGN) CFO nets shares from 9,000 RSU vesting as company withholds stock for taxes - Stock Titan
AxoGen Q4 2025 earnings preview - MSN
Do Options Traders Have Insights on Axogen Stock That We're Unaware Of? - Bitget
Do Options Traders Know Something About Axogen Stock We Don't? - TradingView
(AXGN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
AxoGen, Inc. $AXGN is First Light Asset Management LLC's Largest Position - MarketBeat
ArrowMark Colorado Holdings LLC Buys 332,498 Shares of AxoGen, Inc. $AXGN - MarketBeat
Citizens Maintains Axogen (AXGN) Market Outperform Recommendation - MSN
AXGN SEC FilingsAxogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At Axogen (AXGN) Valuation After AVANCE BLA Approval And Updated Growth Outlook - simplywall.st
AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum - MarketBeat
Lake Street Initiates Coverage of Axogen (AXGN) with Buy Recommendation - MSN
Axogen at Citizens Life Sciences Conference: Strategic Growth Insights By Investing.com - Investing.com Nigeria
Axogen at Citizens Life Sciences Conference: Strategic Growth Insights - Investing.com
AxoGen Q3 2025 Earnings Preview - MSN
AxoGen Conference: AVANCE BLA Approval, Debt Paydown Fuel 2026 Growth Target of 18%+ - MarketBeat
Should Axogen’s 2026 Growth Guidance Amid Wider Losses Require Action From Axogen (AXGN) Investors? - simplywall.st
AxoGen at Leerink Conference: Strategic Growth and Market Expansion By Investing.com - Investing.com Nigeria
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Axogen Inc-Aktie (AXGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DeVinney Erick Wayne | Chief Innovation Officer |
Mar 16 '26 |
Sale |
32.84 |
5,221 |
171,458 |
262,781 |
| Hartley Lindsey Marie | CFO |
Mar 16 '26 |
Option Exercise |
0.00 |
9,000 |
0 |
62,702 |
| Began Marc A | EVP & General Counsel |
Mar 01 '26 |
Option Exercise |
0.00 |
11,250 |
0 |
54,562 |
| Wendell Amy McBride | Director |
Dec 16 '25 |
Option Exercise |
6.91 |
43,684 |
301,963 |
137,510 |
| Wendell Amy McBride | Director |
Dec 16 '25 |
Sale |
29.31 |
43,684 |
1,280,465 |
93,826 |
| Weiler Kathy Johnson | Director |
Dec 16 '25 |
Option Exercise |
6.99 |
40,073 |
280,150 |
46,653 |
| Weiler Kathy Johnson | Director |
Dec 16 '25 |
Sale |
29.55 |
46,653 |
1,378,476 |
0 |
| Hartley Lindsey Marie | CFO |
Dec 15 '25 |
Option Exercise |
8.27 |
14,812 |
122,495 |
46,188 |
| Hartley Lindsey Marie | CFO |
Dec 15 '25 |
Sale |
29.86 |
14,812 |
442,294 |
31,376 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):